Therapeutic Advances in Musculoskeletal Disease

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Musculoskeletal Disease is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
1759-720X · 1759-7218
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,650 USD
Articles in DOAJ
580
Declared review time
18 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-06-04
Indexing
DOAJ
APC
2,650 USD
Declared review time (DOAJ)
18 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

580

Most recent article

last month

Average review time (journal-declared via DOAJ)

18weeks

Works in OpenAlex

810

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

70

i10-index

479

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-04
Added to DOAJ
2021-06-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
98%
ORCID iDs in current deposits
98%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Musculoskeletal disease
Source type
journal
NLM unique ID (PubMed)
101517322
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system

LCC codes

RC925-935

Subject areas

  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Osteoarthritis Treatment and Mechanisms
  • Osteoarthritis Treatment and Mechanisms
  • Bone health and osteoporosis research
  • Bone health and osteoporosis research
Show all subjects (50)
  • Systemic Lupus Erythematosus Research
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Psoriasis: Treatment and Pathogenesis
  • Bone health and treatments
  • Bone health and treatments
  • Systemic Sclerosis and Related Diseases
  • Systemic Sclerosis and Related Diseases
  • Bone Metabolism and Diseases
  • Bone Metabolism and Diseases
  • Bone and Joint Diseases
  • Bone and Joint Diseases
  • Gout, Hyperuricemia, Uric Acid
  • Gout, Hyperuricemia, Uric Acid
  • Vasculitis and related conditions
  • Musculoskeletal pain and rehabilitation
  • Vasculitis and related conditions
  • Musculoskeletal pain and rehabilitation
  • Spine and Intervertebral Disc Pathology
  • Inflammatory Myopathies and Dermatomyositis
  • Spine and Intervertebral Disc Pathology
  • Inflammatory mediators and NSAID effects
  • Inflammatory Myopathies and Dermatomyositis
  • Inflammatory mediators and NSAID effects
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Total Knee Arthroplasty Outcomes
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Total Knee Arthroplasty Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Otitis Media and Relapsing Polychondritis
  • Otitis Media and Relapsing Polychondritis
  • Knee injuries and reconstruction techniques
  • Pain Mechanisms and Treatments
  • Tendon Structure and Treatment
  • Knee injuries and reconstruction techniques
  • Pain Mechanisms and Treatments
  • Tendon Structure and Treatment

Keywords (DOAJ)

  • rheumatology
  • osteoporosis
  • musculoskeletal diseases
  • rheumatic diseases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: